Literature DB >> 24948624

CD20 antibodies induce production and release of reactive oxygen species by neutrophils.

Olle Werlenius1, Rebecca E Riise2, Maria Simpanen1, Johan Aurelius2, Fredrik B Thorén2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24948624     DOI： 10.1182/blood-2014-05-574285

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Human neutrophils express low levels of FcγRIIIA, which plays a role in PMN activation.

Authors:  Josée Golay; Rut Valgardsdottir; Gerta Musaraj; Damiano Giupponi; Orietta Spinelli; Martino Introna
Journal:  Blood       Date:  2019-01-17       Impact factor: 22.113

Review 2.  Molecular Aspects of Resistance to Immunotherapies-Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma.

Authors:  Aleksandra Kusowska; Matylda Kubacz; Marta Krawczyk; Aleksander Slusarczyk; Magdalena Winiarska; Malgorzata Bobrowicz
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

3.  Reactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cells.

Authors:  Olle Werlenius; Johan Aurelius; Alexander Hallner; Ali A Akhiani; Maria Simpanen; Anna Martner; Per-Ola Andersson; Kristoffer Hellstrand; Fredrik B Thorén
Journal:  Oncotarget       Date:  2016-05-31

4.  Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects.

Authors:  Gayane Manukyan; Tomas Papajik; Petr Gajdos; Zuzana Mikulkova; Renata Urbanova; Gabriela Gabcova; Milos Kudelka; Peter Turcsányi; Pavlina Ryznerova; Vit Prochazka; Eva Kriegova
Journal:  Oncotarget       Date:  2017-08-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.